Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001123292-21-000033)

Filing Details

Accession Number:: 0001123292-21-000033
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-01-05 17:32:55
Reporting Period:: 2021-01-02

Accepted Time:: 2021-01-05 17:32:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356090	Precigen Inc.	PGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1583123	L. Rick Sterling	20374 Seneca Meadows Parkway Germantown MD 20876	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-01-02	9,766	$0.00	330,663	No	4	M	Direct
Common Stock	Disposition	2021-01-04	3,487	$10.16	327,176	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2021-01-02	9,766	$0.00	9,766	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,765			No	4	M	Direct

Footnotes

Each restricted unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
The RSUs were granted on January 2, 2018, and the remaining RSUs vest on January 2, 2022.